{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:11:54Z","timestamp":1778047914556,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.athoracsur.2011.04.064","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T04:57:32Z","timestamp":1313902652000},"page":"1428-1434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Transplantation of High Panel-Reactive Antibody Left Ventricular Assist Device Patients Without Crossmatch Using On-Bypass Pheresis and Alemtuzumab"],"prefix":"10.1016","volume":"92","author":[{"given":"Scott D.","family":"Lick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Beckles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Piovesana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Indrikovs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Alexander","family":"Barbagelata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2011.04.064_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-0012.2010.01259.x","article-title":"Management of the sensitized adult heart transplant candidate","volume":"24","author":"Eckman","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.athoracsur.2011.04.064_bib3","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.healun.2006.11.141","article-title":"Treatment of HLA sensitized pre-transplant patients with mechanical support is effective for PRA reduction","volume":"26","author":"Patel","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib4","first-page":"393","article-title":"Desensitization protocol using bortezomib for highly sensitized patients awaiting heart or lung transplants","author":"Weston","year":"2009","journal-title":"Clin Transpl"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1051\/ject\/1999314177","article-title":"Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients","volume":"31","author":"Larson","year":"1999","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.healun.2007.07.042","article-title":"Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and\/or positive retrospective crossmatch","volume":"26","author":"Wright","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0966-3274(93)90060-L","article-title":"The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation","volume":"1","author":"Smith","year":"1993","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V82.3.807.807","article-title":"Effect of Campath-1H antibody on human hematopoietic progenitors in vitro","volume":"82","author":"Gilleece","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"The CAMPATH-1 antigen (CDw52)","volume":"35","author":"Hale","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trim.2008.09.003","article-title":"The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation","volume":"20","author":"Agarwal","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib11","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.tp.0000219235.97036.9c","article-title":"Alemtuzumab (Campath-1H): a systematic review in organ transplantation","volume":"81","author":"Morris","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.healun.2007.04.012","article-title":"Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection","volume":"26","author":"Woodside","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.healun.2008.06.004","article-title":"Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support","volume":"27","author":"Lick","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.tp.0000191940.13473.59","article-title":"T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients","volume":"81","author":"Bloom","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib15","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.tp.0000284808.28353.2c","article-title":"Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury","volume":"84","author":"Ruggenenti","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib17","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/01.tp.0000239268.64408.84","article-title":"Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression","volume":"82","author":"Trzonkowski","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2007.02078.x","article-title":"Homeostatic repopulation by CD28\u2013CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression","volume":"8","author":"Trzonkowski","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-6143.2006.01641.x","article-title":"Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab","volume":"7","author":"Zeevi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2011.04.064_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.healun.2010.12.001","article-title":"Third INTERMACS Annual Report: the evolution of destination therapy in the United States","volume":"30","author":"Kirklin","year":"2011","journal-title":"J Heart Lung Transplant"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497511010319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497511010319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T02:04:12Z","timestamp":1757729052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497511010319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0003497511010319"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2011.04.064","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation of High Panel-Reactive Antibody Left Ventricular Assist Device Patients Without Crossmatch Using On-Bypass Pheresis and Alemtuzumab","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2011.04.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}